41 multiple-sequence-alignment Postdoctoral positions at Pennsylvania State University in Ireland-University-Ranking-2024
Sort by
Refine Your Search
-
. Other than imaging, we are also interested in biochemical, genetic and sequencing approaches to understand gene regulation. This position is open immediately and initially funded for two years. YOUR TASKS
-
Workday, interested candidates must share: Your detailed CV A cover letter describing how your research experience and interests align with the position Contact information for three professional references
-
working collaboratively across multiple complementary projects. This position offers the opportunity to lead an independent research direction within a supportive, well-funded, and highly interactive
-
scholar will have his or her main hub at PSU University Park, but will interact extensively with collaborators at multiple sites, including Washington University in St. Louis and the Penn State College
-
SPECIFICS The Department of Physics at The Pennsylvania State University is seeking to fill multiple post-doctoral positions in theoretical high energy physics, to start between July 2026 and October 2026
-
degree in bioengineering or biomedical engineering, cancer biology, molecular biology, immunology, or a related field is required by the start date. Multiple peer-reviewed publications that demonstrate
-
responsibilities: • Performing world-leading 2D materials synthesis research aligned to the goals of the 2DCC, including both in-house research and collaboration with external users of the 2DCC facility
-
analysis, Integrate capabilities from multiple systems to create seamless user experience, Help domain researchers and understand their needs to design and implement web-based capabilities that support their
-
. JOB DESCRIPTION AND POSITION REQUIREMENTS: The Ozbolat Laboratory in Penn State's College of Engineering has multiple openings for Postdoctoral Scholars in the field of bioprinting, tissue engineering
-
. We have multiple NIH-funded projects to study the influence of FDA-approved GLP-1R agonists on drug seeking and reinstatement in rodents. A newly funded NIH R01 has the goal to determine who may be